IMMUNITYBIO, INC.

IBRX ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2022

Total Assets: $362.4M

Liabilities Breakdown FY2022

Total Liabilities: $812.2M